发明授权
- 专利标题: Dual-use peptidase inhibitors as prodrugs for a therapy of inflammatory and other diseases
- 专利标题(中): 双用肽酶抑制剂作为治疗炎症和其他疾病的前药
-
申请号: US12085096申请日: 2006-11-10
-
公开(公告)号: US08470855B2公开(公告)日: 2013-06-25
- 发明人: Siegfried Ansorge , Klaus Neubert , Ute Bank , Irene Reichstein , Jürgen Faust , Michael Täger , Petra Fuchs , Bianca Senns
- 申请人: Siegfried Ansorge , Klaus Neubert , Ute Bank , Irene Reichstein , Jürgen Faust , Michael Täger , Petra Fuchs , Bianca Senns
- 申请人地址: DE Magdeburg
- 专利权人: IMTM GmbH
- 当前专利权人: IMTM GmbH
- 当前专利权人地址: DE Magdeburg
- 代理商 D. Peter Hochberg; Sean F. Mellino
- 优先权: DE102005054700 20051116
- 国际申请: PCT/EP2006/010818 WO 20061110
- 国际公布: WO2007/057128 WO 20070524
- 主分类号: A61K31/4439
- IPC分类号: A61K31/4439 ; A61K31/444 ; A61K31/427 ; A61K31/4025 ; C07D277/04 ; C07D207/04 ; C07D401/02 ; C07D401/14 ; C07D417/02 ; C07D417/14
摘要:
Compounds of the general formulae (1) and (2) A-B-D-B′-A′ (1) and A-B-D-E (2) in which A and A′ may be identical or different and are the residue in which X is S, O, CH2, CH2CH2, CH2O or CH2NH, and Y is H or CN, and * designates a chiral carbon atom preferably in S- or L-configuration; B and B′ may be identical or different and are an O, N or S containing or non-containing, unsubstituted or substituted, unbranched or branched alkylene residue, cycloalkylene residue, aralkylene residue, heterocycloalkylene residue, heteroarylalkylene residue, arylamidoalkylene residue, heteroarylamidoalkylene residue, unsubstituted or mono- or poly-substituted arylene residue or heteroarylene residue having one or more five-, six- or seven-membered ring(s); D is —S—S— or —Se—Se—; and E is the group —CH2—CH(NH2)—R9 or —CH2—*CH(NH2)—R9 respectively in which R9 is an O, N or S containing or non-containing, unsubstituted or substituted, unbranched or branched alkyl residue, cycloalkyl residue, aralkyl residue, heterocycloalkyl residue, heteroarylalkyl residue, arylamidoalkyl residue, heteroarylamidoalkyl residue, unsubstituted or mono- or poly-substituted aryl residue or heteroaryl residue having one or more five-, six- or seven-membered ring(s) and * designates a chiral carbon atom preferably in the S- or L-configuration; or the acid addition salts thereof with organic and/or inorganic acids; as well as to the use of the compounds of the general formulae (1) and (2) in medicine.
公开/授权文献
信息查询
IPC分类: